Companies / Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc.
THRXCIK 1745020
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 12, 2021 | Gordon Carl L Director | Buy Open-market buy | Common Stock | $9.00M | +563K +3.57% | 16,339,518 | high |
| Oct 12, 2021 | Orbimed Advisors LLC Director | Buy Open-market buy | Common Stock | $9.00M | +563K +3.57% | 16,339,518 | high |
| Oct 12, 2021 | Rock Springs Capital Management LP 10% owner | Buy Open-market buy | Common Stock | $4.00M | +250K +71.57% | 599,320 | high |
| Oct 12, 2021 | Omega Fund VI, L.P. 10% owner | Buy Open-market buy | Common Stock | $3.00M | +188K +35.78% | 711,479 | high |
| Jul 17, 2023 | Foresite Capital Management V, LLC 10% owner | Buy Open-market buy | Common Stock | $1.55M | +523K +14.60% | 4,108,796 | high |
| Dec 29, 2022 | Foresite Capital Management V, LLC 10% owner | Buy Open-market buy | Common Stock | $1.25M | +250K +26.06% | 1,209,275 | high |
| Dec 29, 2022 | Foresite Capital Management V, LLC 10% owner | Buy Open-market buy | Common Stock | $1.25M | +250K +7.50% | 3,585,346 | high |
| Jan 21, 2022 | Gordon Carl L Director | Buy Open-market buy | Common Stock | $1.12M | +112K +0.68% | 16,542,652 | high |